Randomized Study of AM0010 in Combination With FOLFOX Compared to FOLFOX Alone as Second-line Tx in Pts With Meta Pancreatic Cancer That Has Progressed During or Following a First-Line Gemcitabine Containing Regimen
Phase of Trial: Phase III
Latest Information Update: 20 Aug 2017
At a glance
- Drugs Ilodecakin (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Pancreatic cancer
- Focus Registrational; Therapeutic Use
- Acronyms ARTIST 1
- Sponsors ARMO Biosciences
- 20 Apr 2017 According to an ARMO BioSciences media release, results from this trial will be presented at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting.
- 29 Mar 2017 According to an ARMO BioSciences media release, first patient has been dosed.
- 03 Jan 2017 Planned End Date changed from 1 Jan 2019 to 1 Jan 2020.